glp-1 in development Frontiers GLP-1-based therapies for diabetes, obesity

P = 0.0006), and dulaglutide in REWIND trial (HR 0.88

Health tracking tools can support adherence and monitor progress effectively

It is a sign that the peptide is active and the body is adjusting

The Akkermansia Advantage: A Keystone for Gut and Metabolic Health Akkermansia muciniphila, a cornerstone probiotic strain in gut health, strengthens the intestinal barrier and modulates immune and metabolic functions

Despite being discovered first, it received less clinical attention for decades because early research suggested that GIP signaling was impaired in type 2 diabetes, making it seem like an unlikely therapeutic target